市場調査レポート

商品コード

1412629

インシリコ創薬市場：分子タイプ、ワークフロー、治療領域、エンドユーザー別- 世界予測2024-2030年

In-Silico Drug Discovery Market by Molecule Type (Antibodies, Nucleic Acids, Peptides), Workflow (Bioinformatics, Clinical Trials, Discovery), Therapeutic Area, End User - Global Forecast 2024-2030

出版日: 2024年01月15日 | 発行: 360iResearch

| ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 746,257円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 903,397円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,060,537円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,374,817円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

インシリコ創薬市場規模は2023年に26億9,000万米ドルと推計され、2024年には28億6,000万米ドルに達し、CAGR 8.71%で2030年には48億3,000万米ドルに達すると予測されます。

インシリコ創薬の世界市場

主な市場の統計
基準年[2023］	26億9,000万米ドル
予測年[2024］	28億6,000万米ドル
予測年 [2030]	48億3,000万米ドル
CAGR（%）	8.71%

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはインシリコ創薬市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、インシリコ創薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-インシリコ創薬市場の市場規模および予測は？

2-インシリコ創薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-インシリコ創薬市場における技術動向と規制の枠組みは？

4-インシリコ創薬市場における主要ベンダーの市場シェアは？

5-インシリコ創薬市場への参入に適した形態や戦略的手段は？

市場力学
- 促進要因
  - 病気の有病率の上昇と創薬の増加
  - 計算モデルとシミュレーションの改善
  - 個別化医療アプローチへの傾向
- 抑制要因
  - データ統合に伴う懸念
- 機会
  - インシリコ創薬に先進テクノロジーを統合
  - インシリコ創薬のイノベーションを推進するための継続的な研究開発
- 課題
  - 複雑なプロセスと熟練した専門家の不足
市場セグメンテーション分析
市場動向分析
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み

第6章インシリコ創薬市場分子の種類別

抗体
核酸
ペプチド
タンパク質
ベクトル

第7章インシリコ創薬市場：ワークフロー別

バイオインフォマティクス
臨床試験
発見
前臨床試験
タンパク質構造予測
リバースドッキング
ターゲットの特定

第8章インシリコ創薬市場治療領域別

血液疾患
感染症
精神障害
代謝障害
筋骨格系疾患
神経学的障害
腫瘍性疾患
呼吸器疾患
皮膚疾患

第9章インシリコ創薬市場：エンドユーザー別

学術調査機関
受託調査機関
製薬メーカー

第10章南北アメリカのインシリコ創薬市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第11章アジア太平洋地域のインシリコ創薬市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第12章欧州・中東・アフリカのインシリコ創薬市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第13章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ主要企業別の分析

第14章競争力のあるポートフォリオ

主要な企業プロファイル
- Abzena Ltd.
- Aragen Life Sciences Pvt. Ltd.
- BioDuro LLC
- BioNTech SE
- Certara, Inc.
- Charles River Laboratories International, Inc.
- Chemical Computing Group ULC
- ChemPartner PharmaTech Co Ltd
- Creative Biostructure
- Curia Global Inc.
- Evotec SE
- GenScript Biotech Corporation
- InSilico Medicine
- Ligand Pharmaceuticals Incorporated
- Schrodinger Inc.
- Selvita S.A.
- Simulations Plus, Inc.
- Sygnature Discovery
- Viva Biotech Holding Group
- WuXi AppTec
主要な製品ポートフォリオ

第15章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. IN-SILICO DRUG DISCOVERY MARKET RESEARCH PROCESS
FIGURE 2. IN-SILICO DRUG DISCOVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. IN-SILICO DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IN-SILICO DRUG DISCOVERY MARKET DYNAMICS
FIGURE 7. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
FIGURE 8. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
FIGURE 10. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 12. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. IN-SILICO DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. IN-SILICO DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

TABLE 1. IN-SILICO DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IN-SILICO DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 6. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 12. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PRECLINICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PROTEIN STRUCTURE PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REVERSE DOCKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 20. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 48. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 49. CANADA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 52. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 53. MEXICO IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 69. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 70. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 71. CHINA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 74. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 75. INDIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 81. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 82. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 83. JAPAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 93. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 94. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 97. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 98. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 99. SOUTH KOREA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 101. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 102. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 103. TAIWAN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 105. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 106. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. THAILAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 109. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 110. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 111. VIETNAM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 118. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 119. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 120. DENMARK IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 122. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 123. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 124. EGYPT IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 126. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 127. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 128. FINLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 130. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 131. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 132. FRANCE IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 135. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 136. GERMANY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 139. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 140. ISRAEL IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 142. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 143. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 144. ITALY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 147. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 148. NETHERLANDS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 150. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 151. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 152. NIGERIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 154. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 155. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 156. NORWAY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 158. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 159. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 160. POLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 162. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 163. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 164. QATAR IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 178. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 179. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 180. SPAIN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 186. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 187. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 188. SWITZERLAND IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 190. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 191. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 192. TURKEY IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. IN-SILICO DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 202. IN-SILICO DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 203. IN-SILICO DRUG DISCOVERY MARKET LICENSE & PRICING

Product Code: MRR-2E76C3E47FE9

[195 Pages Report] The In-Silico Drug Discovery Market size was estimated at USD 2.69 billion in 2023 and expected to reach USD 2.86 billion in 2024, at a CAGR 8.71% to reach USD 4.83 billion by 2030.

Global In-Silico Drug Discovery Market

KEY MARKET STATISTICS
Base Year [2023]	USD 2.69 billion
Estimated Year [2024]	USD 2.86 billion
Forecast Year [2030]	USD 4.83 billion
CAGR (%)	8.71%

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In-Silico Drug Discovery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In-Silico Drug Discovery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In-Silico Drug Discovery Market, highlighting leading vendors and their innovative profiles. These include Abzena Ltd., Aragen Life Sciences Pvt. Ltd., BioDuro LLC, BioNTech SE, Certara, Inc., Charles River Laboratories International, Inc., Chemical Computing Group ULC, ChemPartner PharmaTech Co Ltd, Creative Biostructure, Curia Global Inc., Evotec SE, GenScript Biotech Corporation, InSilico Medicine, Ligand Pharmaceuticals Incorporated, Schrodinger Inc., Selvita S.A., Simulations Plus, Inc., Sygnature Discovery, Viva Biotech Holding Group, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the In-Silico Drug Discovery Market to forecast the revenues and analyze trends in each of the following sub-markets:

Molecule Type
- Antibodies
- Nucleic Acids
- Peptides
- Proteins
- Vectors
Workflow
- Bioinformatics
- Clinical Trials
- Discovery
- Preclinical Tests
- Protein Structure Prediction
- Reverse Docking
- Target Identification
Therapeutic Area
- Blood Disorders
- Infectious Diseases
- Mental Disorders
- Metabolic Disorders
- Musculoskeletal Disorders
- Neurological Disorders
- Oncological Disorders
- Respiratory Disorders
- Skin Disorders
End User
- Academic & Research Institutes
- Contract Research Organizations
- Pharmaceutical Manufacturers
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the In-Silico Drug Discovery Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the In-Silico Drug Discovery Market?

3. What are the technology trends and regulatory frameworks in the In-Silico Drug Discovery Market?

4. What is the market share of the leading vendors in the In-Silico Drug Discovery Market?

5. Which modes and strategic moves are suitable for entering the In-Silico Drug Discovery Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. In-Silico Drug Discovery Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of diseases and increase in drug discovery
  - 5.1.1.2. Improvement in computational models and simulations
  - 5.1.1.3. Inclination towards personalized medicine approach
- 5.1.2. Restraints
  - 5.1.2.1. Concerns associated with data integration
- 5.1.3. Opportunities
  - 5.1.3.1. Integration of advanced technologies in in-silico drug discovery
  - 5.1.3.2. Ongoing R&D to drive innovation in in-silico drug discovery
- 5.1.4. Challenges
  - 5.1.4.1. Complex process and dearth of skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. In-Silico Drug Discovery Market, by Molecule Type

6.1. Introduction
6.2. Antibodies
6.3. Nucleic Acids
6.4. Peptides
6.5. Proteins
6.6. Vectors

7. In-Silico Drug Discovery Market, by Workflow

7.1. Introduction
7.2. Bioinformatics
7.3. Clinical Trials
7.4. Discovery
7.5. Preclinical Tests
7.6. Protein Structure Prediction
7.7. Reverse Docking
7.8. Target Identification

8. In-Silico Drug Discovery Market, by Therapeutic Area

8.1. Introduction
8.2. Blood Disorders
8.3. Infectious Diseases
8.4. Mental Disorders
8.5. Metabolic Disorders
8.6. Musculoskeletal Disorders
8.7. Neurological Disorders
8.8. Oncological Disorders
8.9. Respiratory Disorders
8.10. Skin Disorders

9. In-Silico Drug Discovery Market, by End User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations
9.4. Pharmaceutical Manufacturers

10. Americas In-Silico Drug Discovery Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific In-Silico Drug Discovery Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa In-Silico Drug Discovery Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. Abzena Ltd.
- 14.1.2. Aragen Life Sciences Pvt. Ltd.
- 14.1.3. BioDuro LLC
- 14.1.4. BioNTech SE
- 14.1.5. Certara, Inc.
- 14.1.6. Charles River Laboratories International, Inc.
- 14.1.7. Chemical Computing Group ULC
- 14.1.8. ChemPartner PharmaTech Co Ltd
- 14.1.9. Creative Biostructure
- 14.1.10. Curia Global Inc.
- 14.1.11. Evotec SE
- 14.1.12. GenScript Biotech Corporation
- 14.1.13. InSilico Medicine
- 14.1.14. Ligand Pharmaceuticals Incorporated
- 14.1.15. Schrodinger Inc.
- 14.1.16. Selvita S.A.
- 14.1.17. Simulations Plus, Inc.
- 14.1.18. Sygnature Discovery
- 14.1.19. Viva Biotech Holding Group
- 14.1.20. WuXi AppTec
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

インシリコ創薬市場：分子タイプ、ワークフロー、治療領域、エンドユーザー別- 世界予測2024-2030年

In-Silico Drug Discovery Market by Molecule Type (Antibodies, Nucleic Acids, Peptides), Workflow (Bioinformatics, Clinical Trials, Discovery), Therapeutic Area, End User - Global Forecast 2024-2030

本レポートは、以下の側面に関する貴重な洞察を提供しています：

本レポートは、以下のような主要な質問に対応しています：

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 インシリコ創薬市場分子の種類別

第7章 インシリコ創薬市場：ワークフロー別

第8章 インシリコ創薬市場治療領域別

第9章 インシリコ創薬市場：エンドユーザー別

第10章 南北アメリカのインシリコ創薬市場

第11章 アジア太平洋地域のインシリコ創薬市場

第12章 欧州・中東・アフリカのインシリコ創薬市場

第13章 競合情勢

第14章 競争力のあるポートフォリオ

第15章 付録